# Arbutus Biopharma Corp: Form 8-K, filed Feb 8, 2018

- Company: [Arbutus Biopharma Corp](/companies/abus.md) (CIK 1447028)
- Form: 8-K
- Filed: 2018-02-08
- Accepted by EDGAR: Feb 8, 2018, 09:27 ET
- Period: 2018-02-07
- Accession: 0001171843-18-000976
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1447028/000117184318000976/f8k_020818.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1447028/000117184318000976/

## Items reported

- Item 2.05: Exit or disposal costs
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1447028/000117184318000976/f8k_020818.htm

Filed Feb 8, 2018.
Source: SEC EDGAR, the filing index for accession 0001171843-18-000976. Last ingested by Listed: Nov 12, 2026, 17:55 ET. No prices; not investment advice.